nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP3A4—Everolimus—kidney cancer	0.0877	0.135	CbGbCtD
Metronidazole—CYP2C8—Pazopanib—kidney cancer	0.0768	0.118	CbGbCtD
Metronidazole—CYP3A4—Temsirolimus—kidney cancer	0.0593	0.0915	CbGbCtD
Metronidazole—CYP2C9—Capecitabine—kidney cancer	0.0558	0.0862	CbGbCtD
Metronidazole—CYP2C8—Erlotinib—kidney cancer	0.0548	0.0846	CbGbCtD
Metronidazole—CYP2C8—Paclitaxel—kidney cancer	0.0501	0.0774	CbGbCtD
Metronidazole—CYP2C8—Sorafenib—kidney cancer	0.0445	0.0688	CbGbCtD
Metronidazole—CYP2C9—Paclitaxel—kidney cancer	0.035	0.054	CbGbCtD
Metronidazole—CYP3A4—Pazopanib—kidney cancer	0.0311	0.0481	CbGbCtD
Metronidazole—CYP2C9—Sorafenib—kidney cancer	0.0311	0.048	CbGbCtD
Metronidazole—CYP3A4—Erlotinib—kidney cancer	0.0222	0.0343	CbGbCtD
Metronidazole—CYP3A4—Paclitaxel—kidney cancer	0.0203	0.0314	CbGbCtD
Metronidazole—CYP3A4—Sorafenib—kidney cancer	0.0181	0.0279	CbGbCtD
Metronidazole—CYP3A4—Vinblastine—kidney cancer	0.0178	0.0275	CbGbCtD
Metronidazole—CYP3A4—Vincristine—kidney cancer	0.0175	0.0271	CbGbCtD
Metronidazole—CYP3A4—Sunitinib—kidney cancer	0.0146	0.0226	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—kidney cancer	0.011	0.0169	CbGbCtD
Metronidazole—Flushing—Capecitabine—kidney cancer	0.000139	0.000394	CcSEcCtD
Metronidazole—Asthenia—Sunitinib—kidney cancer	0.000138	0.000392	CcSEcCtD
Metronidazole—Nausea—Vinblastine—kidney cancer	0.000137	0.00039	CcSEcCtD
Metronidazole—Somnolence—Gemcitabine—kidney cancer	0.000137	0.00039	CcSEcCtD
Metronidazole—Convulsion—Paclitaxel—kidney cancer	0.000137	0.00039	CcSEcCtD
Metronidazole—Nausea—Everolimus—kidney cancer	0.000137	0.000389	CcSEcCtD
Metronidazole—Diarrhoea—Sorafenib—kidney cancer	0.000137	0.000389	CcSEcCtD
Metronidazole—Hypertension—Paclitaxel—kidney cancer	0.000137	0.000389	CcSEcCtD
Metronidazole—Pruritus—Sunitinib—kidney cancer	0.000136	0.000387	CcSEcCtD
Metronidazole—Angiopathy—Capecitabine—kidney cancer	0.000136	0.000385	CcSEcCtD
Metronidazole—Immune system disorder—Capecitabine—kidney cancer	0.000135	0.000383	CcSEcCtD
Metronidazole—Arthralgia—Paclitaxel—kidney cancer	0.000135	0.000383	CcSEcCtD
Metronidazole—Chest pain—Paclitaxel—kidney cancer	0.000135	0.000383	CcSEcCtD
Metronidazole—Mediastinal disorder—Capecitabine—kidney cancer	0.000135	0.000382	CcSEcCtD
Metronidazole—Decreased appetite—Gemcitabine—kidney cancer	0.000134	0.000381	CcSEcCtD
Metronidazole—Hypersensitivity—Dactinomycin—kidney cancer	0.000134	0.000381	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000134	0.000381	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000133	0.000379	CcSEcCtD
Metronidazole—Fatigue—Gemcitabine—kidney cancer	0.000133	0.000378	CcSEcCtD
Metronidazole—Gastrointestinal pain—Vincristine—kidney cancer	0.000133	0.000378	CcSEcCtD
Metronidazole—Dizziness—Sorafenib—kidney cancer	0.000132	0.000376	CcSEcCtD
Metronidazole—Pain—Gemcitabine—kidney cancer	0.000132	0.000375	CcSEcCtD
Metronidazole—Constipation—Gemcitabine—kidney cancer	0.000132	0.000375	CcSEcCtD
Metronidazole—Nausea—Erlotinib—kidney cancer	0.000132	0.000375	CcSEcCtD
Metronidazole—Dry mouth—Paclitaxel—kidney cancer	0.000132	0.000375	CcSEcCtD
Metronidazole—Diarrhoea—Sunitinib—kidney cancer	0.000132	0.000374	CcSEcCtD
Metronidazole—Ataxia—Doxorubicin—kidney cancer	0.000131	0.000372	CcSEcCtD
Metronidazole—Mental disorder—Capecitabine—kidney cancer	0.000131	0.000372	CcSEcCtD
Metronidazole—Asthenia—Dactinomycin—kidney cancer	0.000131	0.000371	CcSEcCtD
Metronidazole—Confusional state—Paclitaxel—kidney cancer	0.00013	0.00037	CcSEcCtD
Metronidazole—Erythema—Capecitabine—kidney cancer	0.00013	0.000369	CcSEcCtD
Metronidazole—Anaphylactic shock—Paclitaxel—kidney cancer	0.000129	0.000367	CcSEcCtD
Metronidazole—Oedema—Paclitaxel—kidney cancer	0.000129	0.000367	CcSEcCtD
Metronidazole—Abdominal pain—Vincristine—kidney cancer	0.000129	0.000366	CcSEcCtD
Metronidazole—Body temperature increased—Vincristine—kidney cancer	0.000129	0.000366	CcSEcCtD
Metronidazole—Liver function test abnormal—Doxorubicin—kidney cancer	0.000129	0.000365	CcSEcCtD
Metronidazole—Infection—Paclitaxel—kidney cancer	0.000129	0.000365	CcSEcCtD
Metronidazole—Flatulence—Capecitabine—kidney cancer	0.000128	0.000364	CcSEcCtD
Metronidazole—Dry skin—Doxorubicin—kidney cancer	0.000128	0.000362	CcSEcCtD
Metronidazole—Dysgeusia—Capecitabine—kidney cancer	0.000127	0.000362	CcSEcCtD
Metronidazole—Dizziness—Sunitinib—kidney cancer	0.000127	0.000362	CcSEcCtD
Metronidazole—Feeling abnormal—Gemcitabine—kidney cancer	0.000127	0.000362	CcSEcCtD
Metronidazole—Shock—Paclitaxel—kidney cancer	0.000127	0.000361	CcSEcCtD
Metronidazole—Vomiting—Sorafenib—kidney cancer	0.000127	0.000361	CcSEcCtD
Metronidazole—Abdominal pain upper—Doxorubicin—kidney cancer	0.000127	0.000361	CcSEcCtD
Metronidazole—Nervous system disorder—Paclitaxel—kidney cancer	0.000127	0.00036	CcSEcCtD
Metronidazole—Thrombocytopenia—Paclitaxel—kidney cancer	0.000127	0.00036	CcSEcCtD
Metronidazole—Rash—Sorafenib—kidney cancer	0.000126	0.000358	CcSEcCtD
Metronidazole—Dermatitis—Sorafenib—kidney cancer	0.000126	0.000358	CcSEcCtD
Metronidazole—Back pain—Capecitabine—kidney cancer	0.000126	0.000357	CcSEcCtD
Metronidazole—Breast disorder—Doxorubicin—kidney cancer	0.000126	0.000357	CcSEcCtD
Metronidazole—Skin disorder—Paclitaxel—kidney cancer	0.000126	0.000357	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000125	0.000356	CcSEcCtD
Metronidazole—Headache—Sorafenib—kidney cancer	0.000125	0.000356	CcSEcCtD
Metronidazole—Muscle spasms—Capecitabine—kidney cancer	0.000125	0.000355	CcSEcCtD
Metronidazole—Hyperhidrosis—Paclitaxel—kidney cancer	0.000125	0.000355	CcSEcCtD
Metronidazole—Diarrhoea—Dactinomycin—kidney cancer	0.000125	0.000354	CcSEcCtD
Metronidazole—Nasopharyngitis—Doxorubicin—kidney cancer	0.000125	0.000354	CcSEcCtD
Metronidazole—Anorexia—Paclitaxel—kidney cancer	0.000123	0.00035	CcSEcCtD
Metronidazole—Vision blurred—Capecitabine—kidney cancer	0.000123	0.000348	CcSEcCtD
Metronidazole—Vomiting—Sunitinib—kidney cancer	0.000122	0.000348	CcSEcCtD
Metronidazole—Body temperature increased—Gemcitabine—kidney cancer	0.000122	0.000347	CcSEcCtD
Metronidazole—Tremor—Capecitabine—kidney cancer	0.000122	0.000346	CcSEcCtD
Metronidazole—Rash—Sunitinib—kidney cancer	0.000121	0.000345	CcSEcCtD
Metronidazole—Dermatitis—Sunitinib—kidney cancer	0.000121	0.000344	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—kidney cancer	0.000121	0.000344	CcSEcCtD
Metronidazole—Headache—Sunitinib—kidney cancer	0.000121	0.000343	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—kidney cancer	0.00012	0.000342	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—kidney cancer	0.00012	0.000342	CcSEcCtD
Metronidazole—Hypersensitivity—Vincristine—kidney cancer	0.00012	0.000341	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—kidney cancer	0.000119	0.000338	CcSEcCtD
Metronidazole—Nausea—Sorafenib—kidney cancer	0.000119	0.000338	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—kidney cancer	0.000118	0.000335	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000118	0.000335	CcSEcCtD
Metronidazole—Malaise—Capecitabine—kidney cancer	0.000117	0.000333	CcSEcCtD
Metronidazole—Insomnia—Paclitaxel—kidney cancer	0.000117	0.000332	CcSEcCtD
Metronidazole—Vertigo—Capecitabine—kidney cancer	0.000117	0.000332	CcSEcCtD
Metronidazole—Asthenia—Vincristine—kidney cancer	0.000117	0.000332	CcSEcCtD
Metronidazole—Syncope—Capecitabine—kidney cancer	0.000117	0.000331	CcSEcCtD
Metronidazole—Leukopenia—Capecitabine—kidney cancer	0.000116	0.000331	CcSEcCtD
Metronidazole—Paraesthesia—Paclitaxel—kidney cancer	0.000116	0.00033	CcSEcCtD
Metronidazole—Vomiting—Dactinomycin—kidney cancer	0.000116	0.000329	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—kidney cancer	0.000116	0.000329	CcSEcCtD
Metronidazole—Somnolence—Paclitaxel—kidney cancer	0.000115	0.000327	CcSEcCtD
Metronidazole—Palpitations—Capecitabine—kidney cancer	0.000115	0.000326	CcSEcCtD
Metronidazole—Rash—Dactinomycin—kidney cancer	0.000115	0.000326	CcSEcCtD
Metronidazole—Nausea—Sunitinib—kidney cancer	0.000114	0.000325	CcSEcCtD
Metronidazole—Loss of consciousness—Capecitabine—kidney cancer	0.000114	0.000325	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—kidney cancer	0.000114	0.000325	CcSEcCtD
Metronidazole—Dyspepsia—Paclitaxel—kidney cancer	0.000114	0.000323	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—kidney cancer	0.000113	0.00032	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—kidney cancer	0.000113	0.00032	CcSEcCtD
Metronidazole—Decreased appetite—Paclitaxel—kidney cancer	0.000112	0.000319	CcSEcCtD
Metronidazole—Hypertension—Capecitabine—kidney cancer	0.000112	0.000319	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000112	0.000318	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000112	0.000317	CcSEcCtD
Metronidazole—Fatigue—Paclitaxel—kidney cancer	0.000112	0.000317	CcSEcCtD
Metronidazole—Diarrhoea—Vincristine—kidney cancer	0.000111	0.000316	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—kidney cancer	0.000111	0.000316	CcSEcCtD
Metronidazole—Asthenia—Gemcitabine—kidney cancer	0.000111	0.000315	CcSEcCtD
Metronidazole—Chest pain—Capecitabine—kidney cancer	0.000111	0.000315	CcSEcCtD
Metronidazole—Arthralgia—Capecitabine—kidney cancer	0.000111	0.000315	CcSEcCtD
Metronidazole—Pain—Paclitaxel—kidney cancer	0.000111	0.000314	CcSEcCtD
Metronidazole—Constipation—Paclitaxel—kidney cancer	0.000111	0.000314	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00011	0.000312	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00011	0.000312	CcSEcCtD
Metronidazole—Pruritus—Gemcitabine—kidney cancer	0.000109	0.00031	CcSEcCtD
Metronidazole—Dry mouth—Capecitabine—kidney cancer	0.000108	0.000308	CcSEcCtD
Metronidazole—Nausea—Dactinomycin—kidney cancer	0.000108	0.000308	CcSEcCtD
Metronidazole—Dizziness—Vincristine—kidney cancer	0.000108	0.000306	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—kidney cancer	0.000107	0.000305	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—kidney cancer	0.000107	0.000305	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—kidney cancer	0.000107	0.000305	CcSEcCtD
Metronidazole—Confusional state—Capecitabine—kidney cancer	0.000107	0.000304	CcSEcCtD
Metronidazole—Feeling abnormal—Paclitaxel—kidney cancer	0.000107	0.000303	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000106	0.000302	CcSEcCtD
Metronidazole—Oedema—Capecitabine—kidney cancer	0.000106	0.000301	CcSEcCtD
Metronidazole—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000106	0.0003	CcSEcCtD
Metronidazole—Diarrhoea—Gemcitabine—kidney cancer	0.000106	0.0003	CcSEcCtD
Metronidazole—Infection—Capecitabine—kidney cancer	0.000105	0.0003	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000105	0.000299	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—kidney cancer	0.000105	0.000297	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—kidney cancer	0.000105	0.000297	CcSEcCtD
Metronidazole—Shock—Capecitabine—kidney cancer	0.000104	0.000297	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—kidney cancer	0.000104	0.000296	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—kidney cancer	0.000104	0.000296	CcSEcCtD
Metronidazole—Nervous system disorder—Capecitabine—kidney cancer	0.000104	0.000296	CcSEcCtD
Metronidazole—Thrombocytopenia—Capecitabine—kidney cancer	0.000104	0.000295	CcSEcCtD
Metronidazole—Vomiting—Vincristine—kidney cancer	0.000104	0.000294	CcSEcCtD
Metronidazole—Skin disorder—Capecitabine—kidney cancer	0.000103	0.000293	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—kidney cancer	0.000103	0.000292	CcSEcCtD
Metronidazole—Urticaria—Paclitaxel—kidney cancer	0.000103	0.000292	CcSEcCtD
Metronidazole—Rash—Vincristine—kidney cancer	0.000103	0.000292	CcSEcCtD
Metronidazole—Hyperhidrosis—Capecitabine—kidney cancer	0.000103	0.000291	CcSEcCtD
Metronidazole—Dermatitis—Vincristine—kidney cancer	0.000103	0.000291	CcSEcCtD
Metronidazole—Body temperature increased—Paclitaxel—kidney cancer	0.000102	0.00029	CcSEcCtD
Metronidazole—Abdominal pain—Paclitaxel—kidney cancer	0.000102	0.00029	CcSEcCtD
Metronidazole—Headache—Vincristine—kidney cancer	0.000102	0.00029	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000101	0.000288	CcSEcCtD
Metronidazole—Anorexia—Capecitabine—kidney cancer	0.000101	0.000287	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—kidney cancer	0.000101	0.000286	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—kidney cancer	0.0001	0.000284	CcSEcCtD
Metronidazole—Vomiting—Gemcitabine—kidney cancer	9.83e-05	0.000279	CcSEcCtD
Metronidazole—Rash—Gemcitabine—kidney cancer	9.74e-05	0.000277	CcSEcCtD
Metronidazole—Dermatitis—Gemcitabine—kidney cancer	9.74e-05	0.000276	CcSEcCtD
Metronidazole—Headache—Gemcitabine—kidney cancer	9.68e-05	0.000275	CcSEcCtD
Metronidazole—Nausea—Vincristine—kidney cancer	9.68e-05	0.000275	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.67e-05	0.000275	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—kidney cancer	9.66e-05	0.000274	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—kidney cancer	9.63e-05	0.000274	CcSEcCtD
Metronidazole—Insomnia—Capecitabine—kidney cancer	9.6e-05	0.000273	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—kidney cancer	9.59e-05	0.000272	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—kidney cancer	9.56e-05	0.000271	CcSEcCtD
Metronidazole—Paraesthesia—Capecitabine—kidney cancer	9.53e-05	0.000271	CcSEcCtD
Metronidazole—Hypersensitivity—Paclitaxel—kidney cancer	9.53e-05	0.000271	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—kidney cancer	9.47e-05	0.000269	CcSEcCtD
Metronidazole—Dyspepsia—Capecitabine—kidney cancer	9.35e-05	0.000265	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—kidney cancer	9.28e-05	0.000264	CcSEcCtD
Metronidazole—Asthenia—Paclitaxel—kidney cancer	9.28e-05	0.000264	CcSEcCtD
Metronidazole—Decreased appetite—Capecitabine—kidney cancer	9.23e-05	0.000262	CcSEcCtD
Metronidazole—Nausea—Gemcitabine—kidney cancer	9.18e-05	0.000261	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Capecitabine—kidney cancer	9.17e-05	0.00026	CcSEcCtD
Metronidazole—Fatigue—Capecitabine—kidney cancer	9.15e-05	0.00026	CcSEcCtD
Metronidazole—Pruritus—Paclitaxel—kidney cancer	9.15e-05	0.00026	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—kidney cancer	9.11e-05	0.000259	CcSEcCtD
Metronidazole—Pain—Capecitabine—kidney cancer	9.08e-05	0.000258	CcSEcCtD
Metronidazole—Constipation—Capecitabine—kidney cancer	9.08e-05	0.000258	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—kidney cancer	9e-05	0.000256	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—kidney cancer	8.98e-05	0.000255	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—kidney cancer	8.94e-05	0.000254	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—kidney cancer	8.94e-05	0.000254	CcSEcCtD
Metronidazole—Diarrhoea—Paclitaxel—kidney cancer	8.85e-05	0.000251	CcSEcCtD
Metronidazole—Feeling abnormal—Capecitabine—kidney cancer	8.75e-05	0.000248	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—kidney cancer	8.74e-05	0.000248	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—kidney cancer	8.7e-05	0.000247	CcSEcCtD
Metronidazole—Gastrointestinal pain—Capecitabine—kidney cancer	8.68e-05	0.000247	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—kidney cancer	8.68e-05	0.000247	CcSEcCtD
Metronidazole—Dizziness—Paclitaxel—kidney cancer	8.56e-05	0.000243	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—kidney cancer	8.44e-05	0.00024	CcSEcCtD
Metronidazole—Urticaria—Capecitabine—kidney cancer	8.44e-05	0.00024	CcSEcCtD
Metronidazole—Body temperature increased—Capecitabine—kidney cancer	8.39e-05	0.000238	CcSEcCtD
Metronidazole—Abdominal pain—Capecitabine—kidney cancer	8.39e-05	0.000238	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—kidney cancer	8.39e-05	0.000238	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—kidney cancer	8.26e-05	0.000235	CcSEcCtD
Metronidazole—Vomiting—Paclitaxel—kidney cancer	8.23e-05	0.000234	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—kidney cancer	8.21e-05	0.000233	CcSEcCtD
Metronidazole—Rash—Paclitaxel—kidney cancer	8.16e-05	0.000232	CcSEcCtD
Metronidazole—Dermatitis—Paclitaxel—kidney cancer	8.15e-05	0.000231	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—kidney cancer	8.11e-05	0.00023	CcSEcCtD
Metronidazole—Headache—Paclitaxel—kidney cancer	8.11e-05	0.00023	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—kidney cancer	8.06e-05	0.000229	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—kidney cancer	7.9e-05	0.000224	CcSEcCtD
Metronidazole—Hypersensitivity—Capecitabine—kidney cancer	7.82e-05	0.000222	CcSEcCtD
Metronidazole—Nausea—Paclitaxel—kidney cancer	7.69e-05	0.000218	CcSEcCtD
Metronidazole—Asthenia—Capecitabine—kidney cancer	7.62e-05	0.000216	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—kidney cancer	7.56e-05	0.000215	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—kidney cancer	7.53e-05	0.000214	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—kidney cancer	7.52e-05	0.000214	CcSEcCtD
Metronidazole—Pruritus—Capecitabine—kidney cancer	7.51e-05	0.000213	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—kidney cancer	7.51e-05	0.000213	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—kidney cancer	7.41e-05	0.00021	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—kidney cancer	7.37e-05	0.000209	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—kidney cancer	7.27e-05	0.000206	CcSEcCtD
Metronidazole—Diarrhoea—Capecitabine—kidney cancer	7.27e-05	0.000206	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—kidney cancer	7.24e-05	0.000206	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—kidney cancer	7.14e-05	0.000203	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—kidney cancer	7.14e-05	0.000203	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.09e-05	0.000201	CcSEcCtD
Metronidazole—Dizziness—Capecitabine—kidney cancer	7.02e-05	0.000199	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—kidney cancer	6.98e-05	0.000198	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—kidney cancer	6.9e-05	0.000196	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—kidney cancer	6.84e-05	0.000194	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—kidney cancer	6.84e-05	0.000194	CcSEcCtD
Metronidazole—Infection—Doxorubicin—kidney cancer	6.8e-05	0.000193	CcSEcCtD
Metronidazole—Vomiting—Capecitabine—kidney cancer	6.75e-05	0.000192	CcSEcCtD
Metronidazole—Shock—Doxorubicin—kidney cancer	6.73e-05	0.000191	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—kidney cancer	6.71e-05	0.000191	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—kidney cancer	6.7e-05	0.00019	CcSEcCtD
Metronidazole—Rash—Capecitabine—kidney cancer	6.69e-05	0.00019	CcSEcCtD
Metronidazole—Dermatitis—Capecitabine—kidney cancer	6.69e-05	0.00019	CcSEcCtD
Metronidazole—Headache—Capecitabine—kidney cancer	6.65e-05	0.000189	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—kidney cancer	6.65e-05	0.000189	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—kidney cancer	6.62e-05	0.000188	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—kidney cancer	6.52e-05	0.000185	CcSEcCtD
Metronidazole—Nausea—Capecitabine—kidney cancer	6.31e-05	0.000179	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.24e-05	0.000177	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—kidney cancer	6.19e-05	0.000176	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—kidney cancer	6.15e-05	0.000175	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—kidney cancer	6.08e-05	0.000173	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—kidney cancer	6.02e-05	0.000171	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—kidney cancer	5.95e-05	0.000169	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.91e-05	0.000168	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—kidney cancer	5.9e-05	0.000168	CcSEcCtD
Metronidazole—Pain—Doxorubicin—kidney cancer	5.85e-05	0.000166	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—kidney cancer	5.85e-05	0.000166	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—kidney cancer	5.64e-05	0.00016	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—kidney cancer	5.6e-05	0.000159	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—kidney cancer	5.44e-05	0.000154	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—kidney cancer	5.41e-05	0.000154	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—kidney cancer	5.41e-05	0.000154	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—kidney cancer	5.04e-05	0.000143	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—kidney cancer	4.91e-05	0.000139	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—kidney cancer	4.84e-05	0.000137	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—kidney cancer	4.68e-05	0.000133	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—kidney cancer	4.53e-05	0.000129	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—kidney cancer	4.35e-05	0.000124	CcSEcCtD
Metronidazole—Rash—Doxorubicin—kidney cancer	4.32e-05	0.000123	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—kidney cancer	4.31e-05	0.000122	CcSEcCtD
Metronidazole—Headache—Doxorubicin—kidney cancer	4.29e-05	0.000122	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—kidney cancer	4.07e-05	0.000115	CcSEcCtD
